Literature DB >> 6751638

In situ identification of T lymphocyte subsets and HLA-DR expressing cells in the human skin tuberculin reaction.

A Scheynius, L Klareskog, U Forsum.   

Abstract

T lymphocyte subsets and HLA-DR expressing cells were studied with an immunohistochemical double staining technique in frozen sections of human skin 6, 48 and 96 hr after intradermal PPD injections. The number of lymphocytes reacting with monoclonal Leu 1 antibodies (all mature peripheral T cells) increased with time. The majority of the T lymphocytes at 48 and 96 hr reacted with Leu 3a ('helper/inducer' phenotype) antibodies and a few with Leu 2a ('suppressor/cytotoxic' phenotype) antibodies. Apposition of T lymphocytes of both subsets to HLA-DR expressing cells occurred in the dermis as well as in the epidermis. The study gives a morphological picture of the cell-mediated immune reactions in delayed type of hypersensitivity consistent with in vitro experiments on proliferative responses to soluble antigens.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6751638      PMCID: PMC1536505     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

2.  Separation of functional subsets of human T cells by a monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

3.  Immunologic functions of Ia-bearing epidermal Langerhans cells.

Authors:  G Stingl; S I Katz; L Clement; I Green; E M Shevach
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

4.  Letter: Substitute for benzidine in myeloperoxidase stains.

Authors:  I S Kaplow
Journal:  Am J Clin Pathol       Date:  1975-03       Impact factor: 2.493

5.  Studies of a human T lymphocyte antigen recognized by a monoclonal antibody.

Authors:  E G Engleman; R Warnke; R I Fox; J Dilley; C J Benike; R Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

6.  Reactivity of a rabbit antiserum against highly purified HLA-DR antigens.

Authors:  L Klareskog; L Trägårdh; J B Lindblom; P A Peterson
Journal:  Scand J Immunol       Date:  1978-03       Impact factor: 3.487

7.  Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents.

Authors:  D Y Mason; R Sammons
Journal:  J Clin Pathol       Date:  1978-05       Impact factor: 3.411

8.  A histochemical analysis of mononuclear cell infiltrates of the skin. II. Delayed hypersensitivity in the human.

Authors:  J L Turk; E J Rudner; C J Heather
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

9.  Studies on human epidermal Langerhans cells. I. Allo-activating and antigen-presenting capacity.

Authors:  L R Braathen; E Thorsby
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

10.  Antibodies to membrane structures that distinguish suppressor/cytotoxic and helper T lymphocyte subpopulations block the mixed leukocyte reaction in man.

Authors:  E G Engleman; C J Benike; E Glickman; R L Evans
Journal:  J Exp Med       Date:  1981-07-01       Impact factor: 14.307

View more
  28 in total

1.  Immunohistological evidence of lymphokine production and lymphocyte activation antigens in tuberculin reactions.

Authors:  M A Fullmer; J Y Shen; R L Modlin; T H Rea
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

Review 2.  T lymphocytes in synovia of patients with rheumatoid arthritis.

Authors:  I Stamenkovic; M Stegagno; S M Krane; J T Kurnick
Journal:  Springer Semin Immunopathol       Date:  1988

3.  Phenotypic characterization of inflammatory cells in phlyctenular eye disease.

Authors:  A M abu el-Asrar; J J Van den Oord; K Geboes; F Facchetti; L Missotten; M H Emarah; V Desmet
Journal:  Doc Ophthalmol       Date:  1988-12       Impact factor: 2.379

4.  Induction of Thy-1 antigen on murine keratinocytes.

Authors:  A Scheynius; L Klareskog; R Holmdahl; P Larsson
Journal:  Immunology       Date:  1986-03       Impact factor: 7.397

5.  Influence of delayed immune reactions on human epidermal keratinocytes.

Authors:  G Kaplan; M D Witmer; I Nath; R M Steinman; S Laal; H K Prasad; E N Sarno; U Elvers; Z A Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

6.  Early cellular responses to intradermal injection of Kveim suspension in normal subjects and those with sarcoidosis.

Authors:  C S Munro; D N Mitchell; L W Poulter; P J Cole
Journal:  J Clin Pathol       Date:  1986-02       Impact factor: 3.411

7.  Immune function in severe, active rheumatoid arthritis. A relationship between peripheral blood mononuclear cell proliferation to soluble antigens and synovial tissue immunohistologic characteristics.

Authors:  D G Malone; S M Wahl; M Tsokos; H Cattell; J L Decker; R L Wilder
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

8.  The cellular responses of tuberculosis and leprosy patients and of healthy controls in skin tests to 'new tuberculin' and leprosin A.

Authors:  J S Beck; S M Morley; J H Gibbs; R C Potts; M I Ilias; T Kardjito; J M Grange; J Stanford; R A Brown
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

9.  Tuberculin-induced delayed-type hypersensitivity reaction in a model of hu-PBMC-SCID mice grafted with autologous skin.

Authors:  A Tsicopoulos; J Pestel; O Fahy; H Vorng; F Vandenbusche; H Porte; L Eraldi; A Wurtz; H Akoum; Q Hamid; B Wallaert; A B Tonnel
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

10.  Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre.

Authors:  R Jansson; A Karlsson; U Forsum
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.